Latest period
$89.90M
YoY change
+15.5%
5Y CAGR
+9.8%
Peak year (2023)
$776.50M
Latest annual
$754.80M
Operating Cash Flow history chart for West Pharmaceutical Services (WST) from 1989 to 2025
Latest: $754.80M
Operating Cash Flow growth chart for West Pharmaceutical Services (WST) from 1989 to 2025
Latest: +15.5%
Operating Cash Flow history table for West Pharmaceutical Services (WST) from 1989 to 2025
| 2025 | $754.80M | +15.5% | +$101.40M | ||
| 2024 | $653.40M | -15.9% | −$123.10M | ||
| 2023 | $776.50M | +7.3% | +$52.50M | ||
| 2022 | $724.00M | +24.0% | +$140.00M | ||
| 2021 | $584.00M | +23.6% | +$111.50M | ||
| 2020 | $472.50M | +28.7% | +$105.30M | ||
| 2019 | $367.20M | +27.2% | +$78.60M | ||
| 2018 | $288.60M | +9.6% | +$25.30M | ||
| 2017 | $263.30M | +20.0% | +$43.90M | ||
| 2016 | $219.40M | +3.3% | +$7.00M | ||
| 2015 | $212.40M | +16.1% | +$29.50M | ||
| 2014 | $182.90M | -17.1% | −$37.60M | ||
| 2013 | $220.50M | +17.7% | +$33.10M | ||
| 2012 | $187.40M | +43.4% | +$56.70M | ||
| 2011 | $130.70M | -5.5% | −$7.60M | ||
| 2010 | $138.30M | +0.4% | +$600.00K | ||
| 2009 | $137.70M | +2.0% | +$2.70M | ||
| 2008 | $135.00M | +4.5% | +$5.80M | ||
| 2007 | $129.20M | -10.2% | −$14.60M | ||
| 2006 | $143.80M | +68.0% | +$58.20M | ||
| 2005 | $85.60M | +24.2% | +$16.70M | ||
| 2004 | $68.90M | -0.4% | −$300.00K | ||
| 2003 | $69.20M | +28.4% | +$15.30M | ||
| 2002 | $53.90M | +64.8% | +$21.20M | ||
| 2001 | $32.70M | -32.7% | −$15.90M | ||
| 2000 | $48.60M | -30.0% | −$20.80M | ||
| 1999 | $69.40M | -2.3% | −$1.60M | ||
| 1998 | $71.00M | +4.9% | +$3.30M | ||
| 1997 | $67.70M | +6.8% | +$4.30M | ||
| 1996 | $63.40M | +37.5% | +$17.30M | ||
| 1995 | $46.10M | -7.4% | −$3.70M | ||
| 1994 | $49.80M | +29.4% | +$11.30M | ||
| 1993 | $38.50M | +13.2% | +$4.50M | ||
| 1992 | $34.00M | -23.4% | −$10.40M | ||
| 1991 | $44.40M | +23.3% | +$8.40M | ||
| 1990 | $36.00M | -16.1% | −$6.90M | ||
| 1989 | $42.90M | — | — |
- 2025$754.80M+15.5%
- 2024$653.40M-15.9%
- 2023$776.50M+7.3%
- 2022$724.00M+24.0%
- 2021$584.00M+23.6%
- 2020$472.50M+28.7%
- 2019$367.20M+27.2%
- 2018$288.60M+9.6%
- 2017$263.30M+20.0%
- 2016$219.40M+3.3%
- 2015$212.40M+16.1%
- 2014$182.90M-17.1%
- 2013$220.50M+17.7%
- 2012$187.40M+43.4%
- 2011$130.70M-5.5%
- 2010$138.30M+0.4%
- 2009$137.70M+2.0%
- 2008$135.00M+4.5%
- 2007$129.20M-10.2%
- 2006$143.80M+68.0%
- 2005$85.60M+24.2%
- 2004$68.90M-0.4%
- 2003$69.20M+28.4%
- 2002$53.90M+64.8%
- 2001$32.70M-32.7%
- 2000$48.60M-30.0%
- 1999$69.40M-2.3%
- 1998$71.00M+4.9%
- 1997$67.70M+6.8%
- 1996$63.40M+37.5%
- 1995$46.10M-7.4%
- 1994$49.80M+29.4%
- 1993$38.50M+13.2%
- 1992$34.00M-23.4%
- 1991$44.40M+23.3%
- 1990$36.00M-16.1%
- 1989$42.90M—
Operating Cash Flow values are taken from West Pharmaceutical Services's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Cash Flow at West Pharmaceutical Services (WST)
Operating Cash Flow for West Pharmaceutical Services (WST): headline value $89.90M · YoY +15.5%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, West Pharmaceutical Services (WST) operating cash flow totalled $754.80M – grew 15.5% year-over-year.
Looking at the 2020–2025 (5 years) stretch, West Pharmaceutical Services operating cash flow compounded at +9.8% per year, with mixed annual results across the window.
West Pharmaceutical Services operating cash flow peaked at $776.50M in 2023; the latest annual figure is $754.80M in 2025 (2.8% below peak).
2023 marks the peak operating cash flow at $776.50M, with the historical low of $32.70M recorded in 2001.
West Pharmaceutical Services Operating Cash Flow by Year
West Pharmaceutical Services Operating Cash Flow 2025: $754.80M
2025's operating cash flow for West Pharmaceutical Services came in at $754.80M, grew 15.5% from 2024.
West Pharmaceutical Services Operating Cash Flow 2024: $653.40M
West Pharmaceutical Services posted operating cash flow of $653.40M in 2024, declined 15.9% below 2023.
West Pharmaceutical Services Operating Cash Flow 2023: $776.50M
In 2023, West Pharmaceutical Services reported operating cash flow of $776.50M, grew 7.3% from 2022. This figure represents the highest annual value in the available history.
West Pharmaceutical Services Operating Cash Flow 2022: $724.00M
West Pharmaceutical Services operating cash flow in 2022 was $724.00M, grew 24.0% from 2021.
West Pharmaceutical Services Operating Cash Flow 2021: $584.00M
West Pharmaceutical Services operating cash flow in 2021 was $584.00M.
See more financial history for West Pharmaceutical Services (WST).
Sector peers by Operating Cash Flow
Healthcare peers of West Pharmaceutical Services (WST), ranked by their latest operating cash flow
| $24.53B | |
| $19.70B | |
| $19.03B | |
| $18.56B | |
| $16.81B | |
| $16.47B | |
| $14.57B | |
| $9.96B |
- $24.53B
- $19.70B
- $19.03B
- $18.56B
- $16.81B
- $16.47B
- $14.57B
- $9.96B
Frequently asked questions
West Pharmaceutical Services (WST) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation